th International Conference on Alzheimer’s Disease & Dementia · Title: A case study on the...
Transcript of th International Conference on Alzheimer’s Disease & Dementia · Title: A case study on the...
Alzheimer’s Disease & Dementia
November 14-15, 2019 | Paris, France
13th International Conference on
S C I E N T I F I C P R O G R A M
conferenceseries.com
SCIENTIFIC PROGRAM DAY 1Thursday, 14th November
08:30-09:00 Registrations
09:00-09:30 Introduction
09:30-09:50 COFFEE BREAK
09:50-11:50 Meeting Hall 01
KEYNOTE LECTURES
MEETING HALL 01 MEETING HALL 02
11:50-13:10 Talks On: Managing DementiaCare Practice and Awareness
Talks On: Alzheimer’s Disease ImagingCauses and Prevention of Alzheimer’s
Memory loss Computed tomography
Alzheimer’s versus Frontotemporal Dementia Neuroimaging techniques
Facing Dementia Functional MRI (fMRI)
Assessment and care planning Medical and Lifestyle Exposures
Community care and Family/lay caregiving Obesity and Lack of Physical Activity
Psychosocial Research in Dementia Disease-causing mutations
13:10-13:15 GROUP PHOTO
13:15-14:00 LUNCH BREAK
MEETING HALL 01 MEETING HALL 02
14:00-16:00Talks On: Alzheimer’s Disease Diagnosis and Symptoms
Talks On: Alzheimer’s Disease Pathophysiology and Dis-ease Mechanisms
Risk Factors of Alzheimer’s Stem cells and Cell death
Cerebrospinal Fluid Biomarker Cellular signaling, kinases, phosphatases, calcium
Epidemiology Cerebral Amyloid Angiopathy
Neurological damage Tau Pathology of Alzheimers Disease
Pathogenesis of Alzheimers Disease
16:00-16:20 COFFEE BREAK
MEETING HALL 01 (16:20-17:00) MEETING HALL 01 (17:00-18:00)
Young Researchers in Alzheimer’s Disease & Dementia
Workshop
https://alzheimers-dementia.neuroconferences.com/
SCIENTIFIC PROGRAM
09:00-10:30 Meeting Hall 01
KEYNOTE LECTURES
10:30-10:50 COFFEE BREAK
MEETING HALL 01 MEETING HALL 02
10:50-12:50 Talks On: Neurodegenerative Diseases Vascular Dementia
Talks On: Therapeutic Targets and Mechanisms for Treat-mentAnimal Models and Translational Medicine
Cognitive behavioral therapy Epidemiology of Neurodegenerative disease
Cognition and Decision-Making Down Syndrome
Brain Stimulation Stroke treatments
Progression and later stages AD transgenic model
Post-stroke dementia Preclinical diagnosis of AD
Hallucinations or Delusions Mild cognitive impairment
12:50-13:35 LUNCH BREAK
MEETING HALL 01 MEETING HALL 02
13:35-15:55
Talks On: Alzheimer’s Clinical Trials and Studies
Talks On: Recent Studies & Case Reports
Preclinical Investigation to Clinical Trials Alzheimers studies
Clinical Studies of Alzheimers Dementia studies
Clinical trial design and methods Breakthrough in Dementia
Quality of Life Trials Case Reports
15:55-16:15 COFFEE BREAK
MEETING HALL 01 (16:15-17:00) MEETING HALL 01 (17:00-18:00)
Young Researchers in Alzheimer’s Disease & Dementia
Workshop
Awards & Closing Ceremony
DAY 2Friday, 15th November
https://alzheimers-dementia.neuroconferences.com/
Petr Zach Charles University, Czech Republic
Magdalena Turek Care Homes Zapiecek, Poland
Catherine Chang Geisel School of Medicine, USA
T Y Chang Geisel School of Medicine, USA
Guadalupe Soria Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain
Xavier López-Gil Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain
Emily Gillett The CareSide, Australia
W Kazana Hirszfeld Institute of Immunology and Experimental Therapy-Polish Academy of Sciences, Poland
Shaymaa Abdulghaffar Abdulmalek Alexandria University, Egypt
Muhammad Asif Rasheed COMSATS University Islamabad, Pakistan
Etrat Hooshmandi Shahid Beheshti University of Medical Sciences, Iran
Mourad Tayebi Western Sydney University, Australia
Weonkuu Chung Kyung Hee University Hospital, South Korea
Arooge Shafi Gosford Private Hospital, Australia
Vesna Vuksanovic University of Aberdeen, UK
Zagrebin V L Volgograd State Medical University, Russia
David Truswell Independent Researcher Consultant Culture Dementia , UK
Soraya L Valles University of Valencia, Spain
Mootaz Salman Sheffield Hallam University, UK
Theresa D Hernandez University of Colorado, USA
Gordon Arbuthnott Okinawa Institute of Science Technology Graduate University , Japan
T. Chris Gamblin University of Kansas , USA
Guangping Gao University of Massachusetts Medical School , USA
PAST AFFILIATESPA
ST A
FFIL
IATE
S
https://alzheimers-dementia.neuroconferences.com/
Judith Miller International Neural Renewal Center, USA
Jeff Zacharias New Hope Recovery Center, USA
Cigdem Akman Columbia University, USA
Konstantin Slavin University of Illinois , USA
Martin Correa University Rovira i Virigili, Spain
Norbert Muller Psychiatry and Psychotherapy Ludwig-Maximilians-University, Germany
Peter Vlerick Ghent University, Belgium
George Fink University of Melbourne, Australia
Crisanto Diez-Quevedo University Autonoma de Barcelona, Spain
Michael Aschner Albert Einstein College of Medicine, USA
Vladimir Konečni Emirates Professor University of California, USA
Kathy sexton Radek Elmhurst College, USA
Sona Nevsimalova 1st Faculty of Medicine Charles University, Czech Republic
Martica Hall Sleep and Chronobiology Center University of Pittsburgh, USA
Sonia Ancoli-Israel Gillin Sleep Research Center University of California, USA
Amos Korczyn Tel Aviv University, Israel
Oana-Claudia Deleanu Romanian Sleep Society University of Medicine Bucharest, Romania
Fangyu Peng The University of Texas, USA
Eef Hogervorst Maastricht University, UK
Lydia Llort Autonomous University of Barcelona, Spain
Amina woods National Institute of Health , USA
Simon Kaja University of Missouri, USA
Toshimitsu Musha Brain Functions Laboratory Inc., Japan
Toru Itakura Wakayama Medical University, Japan
PAST AFFILIATESPA
ST A
FFIL
IATE
S
https://alzheimers-dementia.neuroconferences.com/
PAST AFFILIATESDavide V MorettiNational Institute of Research and Cure for Mental disorders and Dementia, Italy
Guangping Gao University of Massachusetts Medical School , USA
Glenda MacQueen University of Calgary, Canada
Wayne Carter University of Nottingham, UK
Kirk Brower University of Michigan East Medical Campus, USA
Rocco de Filippis Institute of Psychopathology, Italy
Howard Moss National Institutes of Health, USA
Frank Hall National Institutes of Health , USA
Alexander J.A. Groffen VU University, Netherlands
Huiping Zhang Yale University, USA
Trevor Archer University of Gothenburg, Sweden
Patrick Sherry University of Denver, USA
Yama Akbari University of California, USA
Weidong Le Shanghai Jiao Tong University, China
Barry Tolchard University of New England, Australia
Michal Toborek University of Miami , USA
Jacob Barg Member of Israeli Olympic Committee for the Prevention of Sports Doping, Israel
Othman Ghribi University of North Dakota, USA
Frederik Willem Van Leeuwen University of Maastricht, Netherlands
Mark Schwartz Castlewood Treatment Center, USA
Prapapun Chucharoen Prapapun Chucharoen, Thailand
Maciej J. Danilewicz Glen Care Group, UK
P.P.M. Menchetti Founder and President ISLASS (International Society Laser Assisted Spine Surgery), Italy
W S El Masri Keele University, UK
PAST
AFF
ILIA
TES
https://alzheimers-dementia.neuroconferences.com/
Tao Fan Capital Medical University Sanbo Brain Hospital, China
Manish Desai London Spinal Cord Injuries Centre, UK
Naveen Kumar Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, UK
Walter Bini Healthpoint Hospital, UAE
Yuri P Danilov University of Wisconsin-Madison, USA
M. M. Khan Scientist, Univ. of Iowa Hospitals and Clinics, USA
Ana Frances Valencia University, Spain
Davide Moretti Consultant Neurologist National Institute of Research and Cure for Mental disorders and Dementia, Italy
Chia-Chun Chiang Mayo clinic, USA
Martina Bebin Professor of Neurology and Pediatrics UAB Epilepsy Center, USA
Athukoralage Bandara National Dangerous Drugs Control Board of Sri Lanka, Sri Lanka
Mohd Haazik Mohamed Health Education Division, Ministry of Health, Malaysia
Charles W Graham Community College of Aurora, USA
Wolfram Kersten Mind-up GmbH & CO.KG – Bamberg, Germany
Stanislav L. Karsten NeuroInDx,Inc, USA
Felix-Martin Werner Euro Academy Pobneck, Germany
Eric M. Massicotte University of Toronto, Canada
Walter E. Muller University of Frankfurt, Germany
Robert H. Rosenwasser Thomas Jefferson University, USA
Ken yaegaki Nippon Dental University School of Life Dentistry, Japan
Lee-Ellen C. Kirkhorn Chair & Professor Indiana University-Purdue University Fort Wayne, USA
Haifa Al Issa King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia
Joanna B. Strosznajder Polish Academy of Sciences, Poland
PAST AFFILIATES
https://alzheimers-dementia.neuroconferences.com/
Susan Hosseini Nasab The University of Texas Health Science Center at Houston, USA
Pavol Kostka University in Bratislava, Slovakia
Giovanni Grasso University of Palermo , Italy
Massimiliano Visocchi Institute of neurosurgery catholic University of Rome, Italy
Amir Tamiz National Institute of Health, USA
Davide Moretti National Institute of Research and Cure for Mental disorders and Dementia, Italy
Chia-Chun Chiang Mayo clinic, USA
Walter E. Muller University of Frankfurt, Germany
Robert H. Rosenwasser Thomas Jefferson University, USA
Regina Esiovwa Ahumareze University of the West of Scotland, UK
Lee-Ellen C. Kirkhorn Indiana University-Purdue University Fort Wayne, USA
Susan Hosseini Nasab The University of Texas Health Science Center at Houston, USA
Miguel J A Láinez Catholic University of Valencia, Spain
Lilyana Angelov Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, USA
Amir Tamiz National Institute of Health, USA
Si Ching LIM Duke-NUS Medical School, Singapore
Biljana Milatović Clinical center of Serbia, Serbia
Jerzy Leszek Wroclaw Medical University, Poland
PAST AFFILIATES
https://alzheimers-dementia.neuroconferences.com/
Paris Attractions
City H
all
Disneyland Paris
Arc d
e Tr
iom
phe
Plac
e de
la C
onco
rde
Pant
heon
Rodi
n M
useu
m
Not
re D
ame
Dome
Chur
ch
Grand
e Arc
he
de la
Déf
ense
Page 10
conferenceseries.com
Scientific
Pro
gra
m
Alzheimer’s Disease & Dementia
12th International Conference on
October 29-31, 2018 | Valencia, Spain
UK: Conference Series LLC Ltd47 Churchfield Road, London, W3 6AY
Toll Free: +0-800-014-8923
conferenceseries.com2274th Conference
Page 11
conferenceseries.com
DAY-1 October 29, 2018
Meeting Hall: Fenice
Registrations
Opening Ceremony Keynote Forum
IntroductionTitle: Immunohistological analysis of neuronal length changes in the patients with Alzheimer diseasePetr Zach, Charles University, Czech Republic
Group Photo
Networking & Refreshments
Title: Occupational burnout in caregivers working in care homes in PolandMagdalena Turek, Care Homes Zapiecek, Poland
Special Session
Title: Mobilizing cholesterol in the brain to treat Niemann-Pick type C disease and Alzheimer’s diseaseT Y Chang and Catherine Chang, Geisel School of Medicine, USA
Lunch Break
Sessions: Therapeutic Targets and Mechanisms for Treatment | Animal Models and Translational Medicine | Alzheimer’s disease Pathophysiology and Disease Mechanisms | Dementia with Lewy Bodies | Managing Dementia | Care Practice and Awareness
Chair: Magdalena Turek, Care Homes Zapiecek, Poland
Introduction
Title: Early brain connectivity alterations before amyloid deposition in a rat model of Alzheimer’s disease Guadalupe Soria, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), SpainTitle: A case study on the successful transition for seniors living with Alzheimer’s disease from an aged care residential facility to a domestic environment Emily Gillett, The CareSide, AustraliaTitle: Yolkin polypeptide complex from hen egg yolk–isolation, characterization and neuroprotective activity W Kazana, Hirszfeld Institute of Immunology and Experimental Therapy-Polish Academy of Sciences, Poland
Networking & Refreshments
Title: Boosting brain insulin signaling to combat neurotoxicity arising in type 2 diabetes Shaymaa Abdulghaffar Abdulmalek, Alexandria University, Egypt
conferenceseries.com
Page 12
conferenceseries.comconferenceseries.com
Title: In silico identification of novel ApoE4 inhibitor for Alzheimer’s disease therapy Muhammad Asif Rasheed, COMSATS University Islamabad, PakistanTitle: Carbamylated erythropoietin-FC protects hippocampus against Aβ induced memory deterioration in a rat model of Aβ toxicity: Considering Akt/GSK-3β, MAPKs and MMP-2 Etrat Hooshmandi, Shahid Beheshti University of Medical Sciences, Iran
Panel Discussion
DAY-2 October 30, 2018
Meeting Hall: Fenice
Keynote Forum
IntroductionTitle: Investigating age-related dementia in natural higher mammalian models Mourad Tayebi, Western Sydney University, Australia
Sessions: Alzheimer’s Disease: Diagnosis and Symptoms | Managing Dementia | Alzheimer’s disease Imaging | Causes and Prevention of Alzheimer’s | Vascular Dementia | Alzheimer’s Clinical Trials and Studies
Chair: Peace Tsawodzi, Change for Zongo Youth, Ghana
Introduction
Title: Ionizing radiation for awakening LPS treated BV-2 microglia cells Weonkuu Chung, Kyung Hee University Hospital, South Korea
Networking & Refreshments
Title: Pharmacological & non-pharmacological approaches to live well with Dementia Arooge Shafi, Gosford Private Hospital, AustraliaTitle: Cortical thickness and surface area networks in Alzheimer’s disease and behavioral variant frontotemporal dementia Vesna Vuksanovic, University of Aberdeen, UKTitle: Amyloidogenesis under experimental neurodegeneration in rats Zagrebin V L, Volgograd State Medical University, Russia Title: Ranolazina decrease inflammation and oxidative stress in neural cells in primary culture Soraya L Valles, University of Valencia, Spain
Lunch Break
Posters @ Meeting Hall (Foyer)
Poster Judge: Emily Gillett, The CareSide, Australia
Panel Discussion
Page 13
conferenceseries.com
DAY-3 October 31, 2018
Networking Lunch
Awards & Closing Ceremony
Bookmark your Dates13th International Conference on
Alzheimer’s Disease & Dementia
E: [email protected]: alzheimers-dementia.neuroconferences.com/
November 14-15, 2019 | Paris, France